Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Regen BioPharma Inc

RGBPP
Current price
0.39 USD -0.09 USD (-18.77%)
Last closed 0.24 USD
ISIN unknown
Sector Healthcare
Industry Biotechnology
Exchange PINK
Capitalization 8 996 168 USD
Yield for 12 month -41.52 %
1Y
3Y
5Y
10Y
15Y
RGBPP
21.11.2021 - 28.11.2021

Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. It engages in identifying small molecules that inhibit or express NR2F6 leading to immune cell activation for oncology applications, and immune cell suppression for autoimmune disease. The company is involved in the development of its products, and therapies, including HemaXellarate, a cellular therapeutic product of autologous stromal vascular fraction derived from adipose tissue; dCellVax, an autologous dendritic cell which is treated with an siRNA inhibitor of indoleamine-2,3-dioxygenase; tCellVax which is treated with siRNA to inhibit NR2F6 and the cells re-infused to the patient; DiffronC, uses proprietary siRNA in vivo to inhibit cancer growth and activate T cells; and DuroCAR comprising of CAR-T cells which is treated with an shRNA targeting the gene NR2F6. The company was incorporated in 2012 and is based in La Mesa, California. Address: 4700 Spring Street, La Mesa, CA, United States, 91942

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

P/E ratio

Dividend Yield

Current Year

+236 560 USD

Last Year

+235 517 USD

Current Quarter

+59 065 USD

Last Quarter

+59 065 USD

Current Year

+176 560 USD

Last Year

+185 517 USD

Current Quarter

+36 565 USD

Last Quarter

+41 850 USD

Key Figures RGBPP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA
Operating Margin TTM -182.79 %
PE Ratio
Return On Assets TTM -107.31 %
PEG Ratio
Return On Equity TTM
Wall Street Target Price
Revenue TTM 236 560 USD
Book Value -0.59 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM 235 517 USD
Earnings per share -0.017 USD
Diluted Eps TTM -0.017 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY -45.8 %
Profit Margin

Dividend Analytics RGBPP

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History RGBPP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 3:1
Payout Ratio
Last Split Date 05.07.2024
Dividend Date

Stock Valuation RGBPP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM 38.0291
Enterprise Value EBITDA
Price Book MRQ

Financials RGBPP

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators RGBPP

For 52 weeks

0.03 USD 1.17 USD
50 Day MA 0.18 USD
Shares Short Prior Month
200 Day MA 0.55 USD
Short Ratio
Shares Short
Short Percent